Article info

Download PDFPDF

Original article
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis

Authors

  1. Correspondence to Dr Ulf Lindström; ulf.lindstrom{at}gu.se
View Full Text

Citation

Lindström U, Glintborg B, Di Giuseppe D, et al
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis

Publication history

  • Received August 9, 2019
  • Revision received September 16, 2019
  • Accepted September 29, 2019
  • First published October 23, 2019.
Online issue publication 
October 23, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.